FindTrial
Sign In

Comparison of adding magnesium sulphate near the nerves versus giving it through a vein to improve the effect of ropivacaine during an ultrasound-guided shoulder and fore arm nerve block.

Comparing The Effects Of Perineural Magnesium Sulphate With Intravenous Magnesium Sulphate As An Adjuvant To Ropivacaine (0.75%) In Ultrasound Guided Supraclavicular Block: A Randomised Control Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101255
Enrollment
90
Registered
2026-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M966- Fracture of bone following insertion of orthopedic implant, joint prosthesis, or bone plate Health Condition 2: S518- Open wound of forearm

Interventions

Intervention1: Supraclavicular Brachial Plexus Block: Injection Ropivacaine 0.75% Isobaric Control Intervention1: Supraclavicular Brachial Plexus Block: Injection Ropivacaine 0.75% Isobaric & Injectio

Sponsors

M B Government Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Posted for either surgical open reduction or internal fixation of forearm bone fracture under brachial plexus block 2. ASA I, ASA II category.

Exclusion criteria

Exclusion criteria: 1. Patients refusal. 2. Patient allergic to study drugs 3. Deranged coagulopathy, block site infection, peripheral neuropathy, motor neuron disorders and pregnant women will be excluded from the study. 4. Patients already on magnesium theapy

Design outcomes

Primary

MeasureTime frame
To study the duration of analgesia in patients undergoing surgical fixation of fracture forearm under brachial plexus block with Ropivacaine 0.75% with or without perineural or intravenous magnesium sulphate.Timepoint: Duration of analgesia in patients undergoing surgical fixation of fracture forearm under brachial plexus block with Ropivacaine 0.75% with or without perineural or intravenous magnesium sulphate.—

Secondary

MeasureTime frame
1. To study onset and duration of sensory block. 2. To study onset and duration of motor block. 3. To study hemodynamic responses. 4. To study side effects/complications if any.Timepoint: At baseline,24 hours—

Countries

India

Contacts

Public ContactDr VIKRAM BEDI

Department of Anaesthesiology

Vbedimd@gmail.com9829025373

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026